Recent Posts
- Carb-X announces up to $13.8m funding for STIs diagnostic
- Novel Microdevices, Inc. awarded up to $13.8 million from CARB-X for the development of a rapid, point-of-care, molecular diagnostic platform for the detection of sexually transmitted diseases, including antibiotic-resistant infections
- CARB-X Funding Announcement
- Medical Device Accelerator Launchport Adds Tenants
- Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center
Recent Comments